AI-generated summary
The authors conducted a secondary analysis of a randomized controlled trial in 59 women with breast cancer who received cognitive therapy or bright light therapy for eight weeks. They report that several baseline characteristics, such as prior depression history, initial treatment preference, and season of treatment, were associated with differing benefit from each therapy. Replication is needed before these findings can be relied upon.
- Participants
- 59
- Who or what was studied
- Women with breast cancer who received an 8-week cognitive therapy or bright light therapy and completed questionnaires on depression and possible moderating variables
- Limits stated in the abstract
- The authors state that replication is needed, and the analysis is a secondary analysis of a single trial with a modest sample of 59 women.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Bright light therapy, Depression, Randomized controlled trial, Trial registration, Replication, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.